Navigation Links
New IDSAF and NIA Research Grants will Speed Alzheimer’s Microbe Hunt, Says Dr. Leslie Norins of Alzheimer’s Germ Quest, Inc.
Date:6/20/2019

The half-million dollars in Alzheimer’s disease (AD) research grants recently announced by the Infectious Diseases Society of America Foundation, and the possibly millions of dollars of “high priority” grants now offered by the National Institute on Aging to study infectious agents in AD, are a “welcome affirmation” of the need to investigate more thoroughly the possible roles of germs in triggering AD, says Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc.

“This new funding from these two authorities will help alleviate a severe shortage of research grants to follow up many promising leads that viruses, bacteria and other pathogens are involved in AD,” says Dr. Norins. He urges scientists with microbiological talents to apply.

Strangely, he says, several AD advocacy groups appear to still be ignoring microbes, and continue to channel their research grant monies almost exclusively to the traditional topics of amyloid plaques and tau tangles. Dr. Norins attributes this to a lack of infectious diseases experts on their policy and grant review committees.

Dr. Norins also points to a recent article in ALZFORUM, which reported that an anti-viral medication administered to fight hepatitis C might also reduce the later development of Parkinson’s disease. It said, “[This] supports emerging evidence that infections contribute to neurodegeneration.” Dr. Norins reminds, “AD, like Parkinson’s, is a leading neurodegenerative disease.”

Alzheimer’s Germ Quest is a public benefit corporation, headquartered in Naples. Florida. It is self-funded, and neither solicits nor accepts outside donations. Its mission is to accelerate and deepen research into the possibility that a microbiological agent triggers AD. It is the sponsor of the $1 million Challenge Award for the scientist who proves an infectious organism is the cause of AD. Recently, it launched a $100,000 hunt for the world’s first provable case of spontaneous cure of AD.

Read the full story at https://www.prweb.com/releases/new_idsaf_and_nia_research_grants_will_speed_alzheimers_microbe_hunt_says_dr_leslie_norins_of_alzheimers_germ_quest_inc/prweb16390545.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Trivedi Global, Inc. Announces Research by Dahryn Trivedi on the Beneficial Impact of Energy Treated Cefazolin Sodium Antibiotic in Treating Bacterial Infections
2. Research from Ambry Genetics & Mayo Clinic Reveals Differences in the Prevalence of Breast Cancer Genes among Racial and Ethnic Populations
3. Ambry Genetics Research Demonstrates RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management
4. ASGCT To Honor Four Ground-Breaking Researchers at 22nd Annual Meeting
5. ACEA Presents xCELLigence Research Grant to Dr. Teresa Krabbe
6. VCU College of Engineering and Fuzionaire Diagnostics to Pursue Joint Research Applying Novel Radiochemistry Platform to Disease Diagnosis and Drug Discovery
7. uBiome Appoints Dr. Julia Oh, PhD, Skin Microbiome Researcher, to its Scientific Advisory Board
8. uBiome Launches Research Collaboration with doc.ai to Potentially Predict Optimal Supplements for Crohn’s Disease
9. Mount Sinai Researchers Use “Blacklist” Computing Concept as Novel Method to Streamline Genetic Analysis
10. Biocompare Releases Documentary on “What Researchers Need to Know about Antibody Manufacturing”
11. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2019)... ... September 25, 2019 , ... Deep Science Ventures (DSV), a new ... largest independent funder of cancer research. , Deep Science Ventures was founded to create ... of the opportunity from the start, both at the industry and biological level. ...
(Date:9/24/2019)... ... 24, 2019 , ... A-Alpha Bio , a biotechnology ... today that it has raised $2.8M from leading science-focused venture capital firms and ... Cloud Ventures, Boom Capital, Madrona Venture Group, Sahsen Ventures, Washington Research Foundation, and ...
(Date:9/17/2019)... , ... September 17, 2019 , ... VISTAAR ... a primary strategy or as re-assurance / 2nd opinion to their internal strategies they ... Lot of users when going into new markets, or planning to change their product ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... ... ... Pharma LLC will be presenting their latest research in the area of ... Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present ...
(Date:9/24/2019)... ... 24, 2019 , ... Personalized Stem Cells, Inc ... for clinical trial sites and physician investigators. The clinical trial sites are ... , Clinical trial sites are currently located in San Diego and Los Angeles ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... Neurotrophic Factor (BDNF) testing in serum . BDNF plays a vital role in ... growth and differentiation of new neurons in the brain involved in learning, memory, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester Minnesota ... that the U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) ... recommendations for hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics ...
Breaking Biology Technology: